Front Neurosci 16:851394 Chuang Y-C, Chen S-D, Lin T-K et al (2010) Transcriptional upregulation of nitric oxide synthase II by nuclear factor-kappaB promotes apoptotic neuronal cell death in the hippocampus following experimental status epilepticus [J]
Variations in Commercial Preparations Even though 1,000 mcg/mL is the usual amount, different shots can have different levels
What is the Typical Duration of an IV Drip session
They could be employed to reduce the use of steroids, thus helping to mitigate the adverse events associated with them (122)
Loading Phase (Weeks 1 through 4) Tb-500: 2 to 2.5 mg twice weekly (Monday and Thursday) totaling 4 to 5 mg per week Bpc-157: 0.5 mg daily, either as single dose or split into 0.25 mg twice daily Maintenance Phase (Weeks 5 through 8 plus) Tb-500: 2 mg once weekly Bpc-157: 0.25 to 0.5 mg daily Critical Notes Use separate vials and syringes for each peptide Never mix Bpc-157 and Tb-500 in the same syringe Tb-500 can be injected anywhere subcutaneously Bpc-157 should ideally be injected near the injury site The critical implementation detail bears repeating: Bpc-157 and Tb-500 should never be combined into a single vial as peptides lose their effectiveness when mixed incorrectly
Specifically, they neutralize by-products like glyoxal, acrolein and malondialdehyde, all resulting from lipid peroxidation
